Dr. Klein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave # Deskj1-5
Cleveland, OH 44195Phone+1 800-233-2273
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 1986 - 1988
- McGill University Faculty of MedicineClass of 1981
Certifications & Licensure
- FL State Medical License 1994 - 2026
- OH State Medical License 1988 - 2026
- MN State Medical License 1986 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II) Start of enrollment: 1999 Dec 01
- ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement
- Safety Monitoring of Patients Having Pulmonary Vein Ablation Start of enrollment: 2004 May 01
Publications & Presentations
PubMed
- 316 citationsA Test in Context: Myocardial Strain Measured by Speckle-Tracking EchocardiographyPatrick Collier, Dermot Phelan, Allan L. Klein
Journal of the American College of Cardiology. 2017-02-28 - 105 citationsPhase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.Allan L Klein, Massimo Imazio, Paul Cremer, Antonio Brucato, Antonio Abbate
The New England Journal of Medicine. 2021-01-07 - 5 citationsInterleukin-1 Trap Rilonacept Improved Health-Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY.Antonio Brucato, Michelle Z Lim-Watson, Allan Klein, Massimo Imazio, David Cella
Journal of the American Heart Association. 2022-10-18
Journal Articles
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent PericarditisAllan L Klein, Paul Cremer, Martin Lewinter, Sushil A Luis, John F Paolini, The New England Journal of Medicine
- Follow-up Echocardiography of the Right Ventricle in Pulmonary Arterial HypertensionZoran B Popovic, Allan Klein, ScienceDirect
Abstracts/Posters
- [Board 052] Rilonacept in Recurrent Pericarditis: First Efficacy and Safety Data From an Ongoing Phase 2 Pilot Clinical TrialAllan Klein, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Lectures
- Worsening Tricuspid Regurgitation Following Pericardiectomy: What Is the Predictor?American Society of Echocardiography, Scottsdale, Arizona - 2/12/2012
- Highlights in Echocardiography2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Assessment of Diastolic Function Using EchocardiographyWhat Do I Need to Know in ?2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Join now to see all
Authored Content
- Post Ablation PericarditisNovember 2022
- Why Do I Keep Having Chest Pain?March 2021
- Why Do I Keep Having Chest Pain?March 2021
- Recurrent Chest Pain with ST-Segment ElevationMarch 2021
- Treatment of Tuberculous Constrictive Pericarditis with PericardiectomyDecember 2020
- A Challenging Case of Recurrent PericarditisNovember 2020
- Recurrent Pericarditis Post-Pericardiectomy: "Does a Stitch in Time Save Nine?"November 2020
- Atypical Cause of Cardiac Tamponade Following ICD ExtractionOctober 2020
- Management of Refractory Constrictive Pericarditis: A Challenge of TimingAugust 2020
- Management of Refractory Constrictive Pericarditis: A Challenge of TimingAugust 2020
- Join now to see all
Press Mentions
- Structural Valve Imaging Summit Returns with State-of-the-Art Program, Abundant Expert InteractionNovember 8th, 2024
- Cardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating CardiolRx(TM) for the Treatment of Recurrent PericarditisJanuary 17th, 2023
- Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx(TM) for the Treatment of Recurrent PericarditisDecember 12th, 2022
- Join now to see all
Grant Support
- Assessment Of Myocardial Viability By Adenosine Contrast Echocardiography And SINational Center For Research Resources2004
Professional Memberships
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: